Molecular Cancer Biology
A section of Cancers (ISSN 2072-6694).
Section Information
Dysregulation of the complex biological processes that control cell and tissue homeostasis, growth and development under physiological conditions is the key driver of oncogenesis, tumor progression and therapy resistance of cancer. A better understanding of the pivotal molecular events underlying these three aspects of cancer biology will aid the identification of novel targets and the development of new therapeutic approaches for the treatment of this devastating disease. This section covers all aspects of molecular and cellular biology related to the development, progression and therapy of cancer. Topics of interest include:
- oncogenesis and cancer progression;
- cancer immunology;
- drug discovery and targeted therapy;
- tumor invasion and metastasis;
- cancer stem cell biology;
- genomic instability;
- DNA damage and repair;
- cell cycle regulation;
- hypoxia;
- cancer cell metabolism;
- mechanisms of therapy resistance;
- autophagy;
- apoptosis;
- necrosis;
- senescence;
- angiogenesis;
- inflammation and cancer
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Immunogenic Cell Death and Associated Antitumor Immunity (Deadline: 15 May 2024)
- BRCA-Associated Breast Cancer (Deadline: 15 May 2024)
- Single Cell RNA Sequencing in Breast Cancer (Deadline: 15 May 2024)
- Molecular and Cellular Heterogeneity in an Evolving Tumor Landscape: When Diversity Gives Rise to Aggressive and Drug Resistant Cells (Deadline: 20 May 2024)
- The p53 Pathway in Cancer Research (Deadline: 24 May 2024)
- Epigenetic Modifications in Cancer Development (Deadline: 24 May 2024)
- The Long Reach of the Retinoblastoma Tumor Suppressor Pathway (Deadline: 30 May 2024)
- The 10th International MDM2 Workshop—Opening Up New Avenues for MDM2 and p53 Research (Deadline: 31 May 2024)
- Inflammatory and Immunological Markers in Liver Cancers (Deadline: 31 May 2024)
- Deubiquitylating Enzymes and Their Contribution to Human Malignancies (Deadline: 31 May 2024)
- Thioredoxin and Glutathione Systems in Glioblastoma: Mechanisms, Challenges and Targeting Opportunities (Deadline: 1 June 2024)
- Metastatic Melanoma: From Gene Profiling to Targeted Therapy (Deadline: 15 June 2024)
- Lung Cancer: Molecular Pathways, Current Therapies and New Targeted Treatments (Deadline: 20 June 2024)
- Exosomes in Tumor (Deadline: 24 June 2024)
- Cervical Cancer: Study on Molecular Landscape and Protein Biomarkers. Current Diagnostic and Therapeutic Capabilities (Deadline: 25 June 2024)
- The Study of Cancer Susceptibility Genes (Volume II) (Deadline: 25 June 2024)
- Molecular Pathogenesis of Liver Cancers (Deadline: 30 June 2024)
- Molecular Insights into Drug Resistance in Cancer (Deadline: 30 June 2024)
- Identification and Clinical Application of Immunological Receptors Targeting Mutated Antigens Expressed by Solid Tumors (Volume II) (Deadline: 30 June 2024)
- Renal Cell Carcinoma: From Pathology to Therapeutic Strategies (Deadline: 30 June 2024)
- Research in MicroRNA Profiling of Prostate Cancer (Volume II) (Deadline: 30 June 2024)
- Recent Advances in Genetic Studies on Leukemia (Deadline: 30 June 2024)
- Cell Signaling in Cancer and Cancer Therapy (Deadline: 30 June 2024)
- The Biology of CD44 and Its Role in Cancer Progression: Therapeutic Implications (Deadline: 30 June 2024)
- Cell Biology of Cancer Invasion (Deadline: 30 June 2024)
- Gastric Cancers: Molecular Mechanisms, Novel Targets and Immunotherapies: From Bench to Clinical Therapeutics (Deadline: 1 July 2024)
- Molecular Mechanisms in Prostate Cancer Development (Deadline: 1 July 2024)
- Liver Cancers Molecular Biomarkers Predicting Outcome (Deadline: 10 July 2024)
- Glutamine Metabolism in the Onset and Progression of Tumorigenesis (Deadline: 15 July 2024)
- Significance of KRAS Gene Mutations in Colorectal Cancer (Deadline: 25 July 2024)
- The Metabolic Landscape of Gynecological Cancer: Identifying Targets for Therapeutic Intervention (Deadline: 31 July 2024)
- Molecular Mechanisms in Bone and Soft Tissue Sarcomas (Deadline: 31 July 2024)
- Signaling Mechanisms Underlying Gastrointestinal Tract Tumorigenesis (Deadline: 1 August 2024)
- The Response of Prostate Cancers to Androgen Deprivation Therapies (Deadline: 2 August 2024)
- The Role of Cancer Stem Cells (CSCs) in Cancer Immunotherapy (Deadline: 4 August 2024)
- Genetic and Epigenetic Heterogeneity in Cancer (Deadline: 4 August 2024)
- Neuroblastoma: Molecular Insights and Clinical Implications (Deadline: 15 August 2024)
- Molecular Alterations of Endometrial Cancer (Deadline: 20 August 2024)
- Advances in the Molecular Biology and Pathology of Breast Cancer (Deadline: 23 August 2024)
- The Landscape of Transcriptomic Diversity in Oncology (Deadline: 30 August 2024)
- Molecular Targeted Therapy in Cancer (Deadline: 31 August 2024)
- The Warburg Centennial: Past Progress and Future Directions (Deadline: 31 August 2024)
- P53, EMT and DNA Repair: Novel Links Impacting Cancer Progression and Drug Response (Deadline: 31 August 2024)
- Molecular Biology, Diagnosis and Management of Cervical Cancer (Deadline: 31 August 2024)
- Molecular Mechanisms and Clinical Implications of Pancreatic Cancer (Deadline: 1 September 2024)
- Genes in Cancer (Deadline: 1 September 2024)
- Clinical Features and Molecular Pathology of Melanomas (Deadline: 15 September 2024)
- Hodgkin Lymphoma (Volume II) (Deadline: 15 September 2024)
- The Duality of MYB: Normal and Cancer Cell Functions (Deadline: 20 September 2024)
- Exploiting Liabilities in Mechanism of DNA Repair for Cancer Therapy (Deadline: 30 September 2024)
- Tumor Necrosis Factor: Molecular Insights and Clinical Implications (Volume II) (Deadline: 30 September 2024)
- Rhabdomyosarcoma: Still Unresolved Questions but New Perspectives (Deadline: 30 September 2024)
- Comprehensive Genomic Profiling for Metastatic Breast Cancer: Current Status and Future Perspectives (Deadline: 30 September 2024)
- Sex Differences in Cancer (Deadline: 15 October 2024)
- Growth Factors and Receptor Tyrosine Kinases in Development, Regeneration, and Tumorigenesis (Deadline: 15 October 2024)
- Emerging Insights into Cell Death in Cancer (Deadline: 25 October 2024)
- The Analysis of Circulating Tumor Cells (CTCs): New Insights into the Biology of Cancers (Deadline: 31 October 2024)
- Transcription Factors in Breast Cancer (Deadline: 31 October 2024)
- Microtubule-Associated Proteins (MAPs) and Cancers (Deadline: 31 October 2024)
- Updates on the Molecular Profile of Gastrointestinal Stromal Tumors (Volume II) (Deadline: 31 October 2024)
- Oxidative Stress and Cancer: Possible Beneficial and Antioxidant Strategies (Volume II) (Deadline: 15 November 2024)
- Molecular and Genetic Diagnosis and Targeted Therapy of Myeloproliferative Neoplasms (Deadline: 15 November 2024)
- Molecular Mechanisms in Head and Neck Cancer (Deadline: 15 November 2024)
- Mitochondrial Uncoupling and Cancer (Deadline: 23 November 2024)
- Advances in Genetic and Molecular Approaches to Skin Cancer (Deadline: 25 November 2024)
- Updates on the Genetics of Myeloid Malignancies (Deadline: 25 November 2024)
- Rare Gynecological Cancers (Deadline: 25 November 2024)
- Exploring the Genetic and Epigenetic Factors in Leukemia and Lymphoma (Deadline: 30 November 2024)
- Natural Compounds in Cancers (Deadline: 30 November 2024)
- Novel Insights in Ocular and Orbital Oncology: From Molecular Biology to Treatment Strategies (Deadline: 30 November 2024)
- Lung Cancer—Molecular Insights and Targeted Therapies (Volume II) (Deadline: 30 November 2024)
- Genomics of Hematologic Cancers (Volume II) (Deadline: 30 November 2024)
- Oncogenesis of Lymphoma (Deadline: 30 November 2024)
- MAPK/Akt Signaling Pathways: Function, Regulation, Signaling, and Implications for Cancer Treatment (Deadline: 30 November 2024)
- Blood Stem Cell and Hematological Malignancies (Deadline: 30 November 2024)
- Cutaneous Lymphoma (Deadline: 1 December 2024)
- Urology Cancers: Drug Resistance and Signaling Mechanism (Deadline: 15 December 2024)
- Mechanisms of mRNA Translation in Pancreatic Cancer (Deadline: 15 December 2024)
- Mantle Cell Lymphoma: From Biology to Therapy (Deadline: 25 December 2024)
- Alternative Cell Death Modes in Regulating Cancer Stem Cells and Therapeutic Strategies (Deadline: 25 December 2024)
- Precision Oncology for Rare Skin Cancers (Deadline: 31 December 2024)
- Molecular Genetics, Signaling Pathways, and Therapeutic Strategies for Liver Cancer (Deadline: 31 December 2024)
- Genomic Alterations in Leukemia (Volume II) (Deadline: 31 December 2024)
- EGFR Signaling in Cancer (2nd Edition) (Deadline: 31 December 2024)
- Lung Cancer Proteogenomics: New Era, New Insights (Deadline: 15 January 2025)
- Hypoxic Signaling: Relation to Cancer Progression and Cancer Stem Cell Regulation (Deadline: 15 January 2025)
- Multiple Signaling Pathways in Ovarian Cancer (Deadline: 31 January 2025)
- The Role of Regulatory Non-Coding RNA in Cancer (Deadline: 31 January 2025)
- Alterations in Ribosome Structure, Integrity and Function in Cancer and in Response to Cancer Treatments (Deadline: 31 January 2025)
- The Role of Apoptosis and Autophagy in Cancer (Deadline: 28 February 2025)
- New Insights into Cell Death and Drug Resistance in Cancer (Deadline: 28 February 2025)
- Cell Migration and Invasion in Cancer (Deadline: 28 February 2025)
- Recent Advances in the Molecular Genetics of Sarcomas (Deadline: 1 March 2025)
- Oxidative Phosphorylation System Dysfunction Role and Mechanisms in Cancer and Its Therapies (Deadline: 20 March 2025)
- Molecular Biology of Urological Cancers (Deadline: 31 March 2025)
- The Role of Ferroptosis in Cancer (Deadline: 31 March 2025)
- Advances in Imaging Techniques of Molecular Oncology (Deadline: 15 April 2025)
- Clinical Applications of Integrative Analysis of Validated Somatic and Germline Genomic Results in Oncology (Deadline: 25 April 2025)
- Molecular Pathology of Brain Tumors (Deadline: 30 April 2025)
- Novel Molecular Interceptive and Therapeutic Targets and Noninvasive Prognostic and Predictive Biomarkers in Prostate Cancer (Deadline: 30 April 2025)
- Cell Adhesion in Human Cancer (Deadline: 31 May 2025)
- Molecular Biology, Diagnosis and Management of Endometrial Cancer (Deadline: 12 July 2025)
- Cancer Genetics and Epigenetics: Their Roles and Clinical Implications (Deadline: 15 September 2025)
- Giant-Cell-Containing Tumors of Bone—New Insights into Pathobiology, the Clinical Setting and Targeted Therapies (Deadline: 30 September 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- miRNAs: New Insights in Tumor Biology
- Molecular Pathways in Cancers
- Prostate Cancer—from Molecular Mechanisms to Clinical Care
- Recent Advances in Pancreatic Ductal Adenocarcinoma
- Recent Advances in Tumor Suppressor (Closed)
- Regulatory and Non-Coding RNAs in Cancer Epigenetic Mechanisms
- Role of Stromal Cells in Determining Tumor and Cancer Stem Cell Behaviors and Therapeutic Response
- Stemness and Drug-Persistence in Cancer
- Tumor Evolution: Progression, Metastasis and Therapeutic Response